Biophysics of recellularized porcine cardiac extracellular matrix for myocardial tissue engineering
Myocardial Infarction (MI) causes severe damage to cardiac muscles and remains the leading cause for congestive heart failure. Donations’ shortage for heart transplantations and limited benefits from conventional medications and surgeries have motivated researchers to find alternative ways to res...
Saved in:
Main Author: | |
---|---|
Other Authors: | |
Format: | Theses and Dissertations |
Language: | English |
Published: |
2015
|
Subjects: | |
Online Access: | https://hdl.handle.net/10356/65184 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Institution: | Nanyang Technological University |
Language: | English |
Summary: | Myocardial Infarction (MI) causes severe damage to cardiac muscles and remains the
leading cause for congestive heart failure. Donations’ shortage for heart transplantations
and limited benefits from conventional medications and surgeries have motivated
researchers to find alternative ways to restore heart function post-MI, where a large scale
of myocardium is scarred and no longer contractile.
Myocardial Tissue Engineering (MTE) using scaffolds with or without cell seeding offers
potential for in-vitro engineering of a myocardium-substitute construct for
transplantation. Yet, many potential scaffold materials studied fail to give a physiological
relevant thickness as compared to native myocardium in their intact form (10-15mm).
Most of them also fail to provide matched modulus and flexibility that may hinder the
proper mechanical functioning of the construct. Moreover, they are mostly lacking the
optimal infrastructure resembling that of native myocardium to support desired cell
engraftment.
Our lab has developed and patented the decellularization of porcine left ventricle wall,
yielding acellular porcine cardiac extracellular matrices (ECM), which are of surgical
applicable transplant dimensions. These acellular cardiac matrices retained major ECM
proteins and preserved inherent vasculature to address the above-mentioned limitations
of existing biomaterials.
In this PhD research, the ECM’s potential as a scaffold for cardiac restoration therapy was
further investigated from the material engineering point of view. We aim to
experimentally show that improved biophysical functionality of reseeded ECM-based
cardio-mimetic constructs can be achieved through optimized culturing methods; and to
rationalize the results with computational modeling and material biophysical properties
correlations.
Characterization on mechanical, thermal, surface conformational, protein adsorption
kinetic, and electrical properties was performed. Strong focus was put on the
biomechanical properties as it crucially determines a scaffold’s functional compatibility
with the host tissue upon implantation. Sample mounting, experimental methods (in both
uniaxial and biaxial tensile settings) and computational viscoelastic analytic tool were
particularly developed for this purpose to test our unique thick and soft ECM.
To provide a basis for evaluation, native adult porcine myocardium, which possesses the
closest-to-human anatomy, was thoroughly characterized in the same fashion. This
allowed us to identify the similarities and discrepancies between ECM and native
myocardium. The effect of recellularization towards a more native-mimicking construct
was then evaluated in terms of cell proliferation and the recovery of the native-like
biophysical properties. Four different seeding methods and three different culturing
regimes in static and dynamic conditions were employed.
The results from this research thesis supports our hypothesis that the acellular ECM
scaffold alone, and more so when reseeded with human bone-marrow derived
mesenchymal stem cells (MSC), possesses biophysical properties that are close to those
of the native myocardium. Its potential to be a suitable cardio-mimetic construct for
myocardial tissue engineering was reaffirmed, supporting our vision to step forward in
putting the ECM scaffold as an off-the-shelf biomedical product for diseased myocardium
replacement and cardiac regeneration therapy. |
---|